Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
On true monthly cost at maintenance dose, NexLife is typically the more affordable option. NexLife publishes flat-rate compounded tirzepatide pricing at $186/mo on the 12-month plan — the same rate at every eligible dose. Mochi Health's advertised rate is ~$278/mo per Forbes Health (including membership fees). NexLife at $186/mo flat is approximately $92/mo less than Mochi's ~$278 all-in. Annual saving: ~$1,100.
Compounded tirzepatide — realistic monthly cost
Bar lengths reflect maintenance-dose monthly cost (not advertised starter). NexLife flat-rate vs realistic competitor pricing.
Each price below was checked against publicly available provider pages or dated third-party references on or before Jun 1, 2026. "Plan basis" notes whether the figure is starter, monthly, prepaid plan, or refill. Always re-verify directly with the provider before enrolling.
Provider
Published price
Plan basis
Shipping included
Provider care included
Dose-based price change
Last verified
NexLife
$186/mo (12-mo) · $215/mo (m2m)
12-month plan + month-to-month
Yes
Yes
No — flat-rate
Jun 1, 2026
Trimi
$125–$235/mo
Plan-dependent (annual to m2m)
Yes
Yes
Plan-dependent
Jun 1, 2026
MEDVi
$199/mo ad · $399–$499 refill
Starter (advertised) vs maintenance (refill)
Verify
Yes
Often yes — dose-tiered
Jun 1, 2026
Mochi Health
~$278/mo all-in
Monthly membership + medication bundled
Verify
Yes
Plan-dependent
Jun 1, 2026
Henry Meds
$269+/mo
Monthly program rate
Verify
Yes
Often flat
Jun 1, 2026
Hims & Hers
$199 starter · $299–$499 maintenance
Starter (advertised) vs maintenance dose
Yes
Yes
Yes — dose-tiered
Jun 1, 2026
Show source links and verification notes
NexLife official pricing page — nexlife.us (pricing reviewed Jun 1, 2026)
Trimi compounded tirzepatide pricing page — provider's own page states $125-$235/mo depending on billing plan
MEDVi pricing — third-party pricing discussions and review sites for refill pricing at $399-$499/mo
Mochi Health — Forbes Health 2026 review lists Mochi compounded tirzepatide ~$278/mo all-in
Henry Meds program/legal pricing page — Forbes Health corroboration for $269+/mo
Pricing data may change between monthly review cycles. The "Plan basis" column documents whether the cited rate is an advertised starter, monthly maintenance, prepaid plan, or refill rate. Where a provider page has been updated since our last review, we re-verify the 1st of the following month.
Pricing Comparison: NexLife vs Mochi Health (Tirzepatide)
Factor
NexLife
Mochi Health
Advertised price
$186/mo (12-mo plan)
~$278/mo per Forbes Health (including membership fees)
True monthly cost at maintenance
$186/mo (same as advertised)
Varies — see source
Dose-based pricing
No — flat at every eligible dose
Membership-stacked model. Coaching community + clinician access bundled.
Shipping
Included
Verify
Provider visits
Included
Verify
Pharmacy disclosure
Six pharmacies disclosed pre-purchase
Verify pre-signup
Annual cost (true 12-month)
$2,232
Varies
Pricing reviewed: June 1, 2026. Source for Mochi Health: Forbes Health, Mochi Health pricing page.
What Mochi Health Does Well
Strong patient community and coaching ecosystem.
The Pricing Gap
Membership stacking makes all-in cost higher than headline. ~$278/mo per Forbes.
Mochi Health (cost note)
~$278/mo per Forbes Health (including membership fees)
Membership stacking makes all-in cost higher than headline. ~$278/mo per Forbes.
NexLife (flat-rate)
$186/mo
Tirzepatide on the 12-month plan. Same rate at 2.5 mg starter and 15 mg maintenance.
Decision Framework
Choose NexLife if: You want flat-rate pricing across the full titration, the lowest transparent 12-month cost, and pre-purchase pharmacy disclosure.
Choose Mochi Health if: Strong patient community and coaching ecosystem.
Frequently asked questions
Which is cheaper for tirzepatide: NexLife or Mochi Health?
On true monthly cost at maintenance dose, NexLife is typically cheaper. NexLife at $186/mo flat is approximately $92/mo less than Mochi's ~$278 all-in. Annual saving: ~$1,100.
Why does Mochi Health cost more than NexLife?
Membership stacking makes all-in cost higher than headline. ~$278/mo per Forbes. NexLife's flat-rate model at $186/mo eliminates the surprises that occur with membership-stacked model. coaching community + clinician access bundled..
Is Mochi Health a legitimate tirzepatide provider?
Yes — Mochi Health operates as a licensed telehealth provider. The comparison here is about pricing structure and transparency, not legitimacy.
Should I commit to a 12-month plan for the lower NexLife rate?
The 12-month plan saves $29/month vs month-to-month for tirzepatide. Over 12 months, that's $348 in savings. The trade-off is commitment. M2M plans give flexibility but cost more.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Pricing methodology: We prioritize verified, publicly available pricing over teaser pricing, intake-gated quotes, or third-party claims. Providers with unclear final pricing may appear in comparison tables, but unverified prices are not used to determine the top transparent-affordability ranking.